Find BioTech Investors in Maryland
With over 100,000 investors actively prospecting, our mission is to help founders secure meetings and get funded in weeks not months.
Find the right investors for your company
We found 121 investors in Maryland investing in BioTech on Angels Partners
Our team is dedicated to scouting
investors from all around the world.
FinTech, Hardware, SaaS … we diversify our portfolio of
investors to give you the best chance of finding the right partner.
Mark Anderson
Investing in Software (Web Marketplace Saas..) &b... San Francisco Califor..., U.S.A.
Previous Investments
- • BioInformatics: $21000000
- • Neosec: $15000000 (Series A)
- • Spiff: $46000000 (Series B)
Mark Anderson
San Francisco California - Chicago Illinois - Baltimore Maryland - Annapolis Maryland - Bellingham Washington - Ontario California - Idaho Falls Idaho - Illinois - Pleasanton (CA), U.S.A.
Investing In
Software (Web Marketplace Saas..) • Other • IT (& TMT) • Education • BioTech • Businesses Solutions • FinTech (& Financials services) • Energy • Retail (& E-Commerce) • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Web Security (& Privacy) • Cloud Services (& Infrastructure) • Logistics (& Distribution) • Medical Devices (& Hospital Services) • Consumer
Description
Own a Hedge Fund that is constantly looking for businesses that have great growth potential
Linked In Description:
Investment Banking for Tech companies in Enterprise and Consumer segments. A veteran in Enterprise, Mobile and Digital Media, Corporate Development VR, Voice Powered AI, Smart Devices, Mobile Advertising, Gaming, Artificial Intelligence, and IoT. Extensive deal-making with Mobile Carriers, Major Brands, Media Companies, Advertisers, Enterprise Sales, and Business Development, OEM's, Internet of Things (IoT) and Venture Capital. Entrepreneur, Angel Investor.
Ed Mathers
Investing in IT (& TMT) • BioTech • Har... Washington (DC) , Mar..., U.S.A.
Previous Investments
- • Trevi Therapeutics: $30000000 (Series C)
- • Synlogic: $42000000 (Series C)
- • Synlogic: $29400000 (Series A)
- • ObsEva: (Series B)
- • Mirna Therapeutics: $41800000 (Series D)
- • Mirna Therapeutics: $34500000 (Series C)
- • Lumena Pharmaceuticals: $45000000 (Series B)
- • Lumos Pharma: $14000000 (Series A)
- • Motus Therapeutics: $8000000 (Series B)
- • Motus Therapeutics: $25000000 (Series B)
- • Motus Therapeutics: $19000000 (Series A)
- • Motus Therapeutics: $21000000 (Series A)
- • Intarcia Therapeutics: $160000000 (Series C)
- • Intarcia Therapeutics: $50000000 (Debt Financing)
- • Intarcia Therapeutics: $5000000 (Debt Financing)
- • Intarcia Therapeutics: $50000000 (Series B)
- • Satori Pharmaceuticals: $15000000 (Venture Round)
- • Satori Pharmaceuticals: $7000000 (Series B)
- • Satori Pharmaceuticals: $22000000 (Series A)
- • Affinia Therapeutics: $110000000 (Series B)
- • Affinia Therapeutics: $60000000 (Series A)
- • Code Biotherapeutics: $10000000 (Seed Round)
- • Sentry: $60000000 (Series D)
- • Sentry: $40000000 (Series C)
- • MBX Biosciences: $34600000 (Series A)
- • Shape Therapeutics: $35500000 (Series A)
- • Reneo Pharmaceuticals: $50000000 (Series A)
- • Curzion Pharmaceuticals: (Venture Round)
- • Mirum Pharmaceuticals: $120000000 (Series A)
- • Amplyx: $118280000 (Later stage VC)
- • Allakos: $100000000 (Later stage VC)
- • Korro Bio: $91500000 (Later stage VC)
- • Bestow: $70000000 (Later stage VC)
- • Pionyr Immunotherapeutics: $62000000 (Later stage VC)
- • Sitetracker: $42000000 (Later stage VC)
- • DataVisor: $40000000 (Later stage VC)
- • FIRE1: $40000000 (Later stage VC)
- • Xoc Pharmaceuticals: $30000000 (Early stage VC)
- • MindTickle: $27000000 (Later stage VC)
- • Logikcull: $25000000 (Later stage VC)
- • Infoworks: $25000000 (Later stage VC)
- • Metacrine: $22000000 (Later stage VC)
- • Fyusion: $22000000 (Later stage VC)
- • Drop: $21000000 (Early stage VC)
- • Greenlight Financial Technology: $16000000 (Early stage VC)
- • Lyric: $15500000 (Early stage VC)
- • Igneous Systems: $15000000 (Later stage VC)
- • Timescale: $12400000 (Early stage VC)
- • Tigera: $10000000 (Later stage VC)
- • Akouos: $7500000 (Seed Round)
- • Curisium: $3500000 (Seed Round)
- • Aquabyte: $3500000 (Seed Round)
- • Genies: $3000000 (Other)
- • Lily: $2000000 (Seed Round)
- • Vizbee: (Later stage VC)
Ed Mathers
Washington (DC) - Maryland, U.S.A.
Investing In
IT (& TMT) • BioTech • Hardware (& Manufacturing) • Energy • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Consumer • Pharmaceutical (& Medicine)
Gregory Harriman
Investing in BioTech • Medical Devices (& Ho... Radnor, Pennsylvania ..., U.S.A.
Previous Investments
- • VenatoRx Pharmaceuticals: $42000000 (Later stage VC)
- • ENB Therapeutics: $2290000 (Seed Round)
- • Pillo Health: $1500000 (Later stage VC)
- • SIRPant Immunotherapeutics: $1500000 (Seed Round)
- • Oncora Medical: $1300000 (Later stage VC)
- • Genome Profiling: $880000 (Later stage VC)
- • WellSheet: $800000 (Seed Round)
- • TalexMedical: $500000 (Seed Round)
- • WellTrackONE, Corporation: $200000 (Later stage VC)
- • Palvella Therapeutics: (Later stage VC)
- • Cytovas: (Later stage VC)
- • Olive Devices: (Later stage VC)
Gregory Harriman
Radnor, Pennsylvania - Washington - Delaware - New York City - Maryland, U.S.A.
Investing In
BioTech • Medical Devices (& Hospital Services) • Pharmaceutical (& Medicine)
Description
Partner, Chief Investment Officer at BioAdvance
Hal Shelton
Investing in Software (Web Marketplace Saas..) &b... Rockville, Maryland ,..., U.S.A.
Previous Investments
- • Emu Technology: $5000000 (Early stage VC)
- • Bandura: $4010000 (Early stage VC)
- • Bright Greens: $2000000 (Seed Round)
- • Machfu: $1600000 (Seed Round)
- • Dark Cubed: $1250000 (Seed Round)
- • Atomicorp: $1000000 (Seed Round)
- • Huntress Labs: $750000 (Seed Round)
- • TrackOFF: (Seed Round)
- • NewConnect: (Later stage VC)
- • GroupSense: (Seed Round)
- • N5 Sensors:
- • StreamLink Software: $10000000 (Venture Round)
- • StreamLink Software: $3500000 (Series A)
Hal Shelton
Rockville, Maryland - Vienna, Virginia, U.S.A.
Investing In
Software (Web Marketplace Saas..) • BioTech • Hardware (& Manufacturing) • Web Security (& Privacy) • Material Science
Description
Principal at Blu Venture Investors
Paxton Major
Investing in BioTech Maryland , Cambridge,..., U.S.A.
Previous Investments
- • QbDVision: $15000000 (Series A)
Paxton Major
Maryland - Cambridge, Massachusetts - Washington (D.C.), U.S.A.
Investing In
BioTech
Description
Senior Associate at Northpond Ventures
John May
Investing in Software (Web Marketplace Saas..) &b... McLean Virginia , Vie..., U.K.
Previous Investments
- • Sensics: $1500000
- • Sensics: $710000
- • Sensics:
- • Smarthinking:
- • ObjectVideo Labs:
John May
McLean Virginia - Vienna Virginia - San Mateo California - London - Richmond Virginia - Annapolis Maryland - St. Louis Missouri - Warrenton Virginia - Columbia South Carolina - Virginia - , U.K.
Investing In
Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • Hardware (& Manufacturing) • A.I. (& Big Data) • Medical Devices (& Hospital Services)
Description
Angel Investor and Venture Fund Manager
I am an angel investor and prior general partner in venture funds,was Chair of the Angel Capital Association and work with angel groups in the Washington area.
Sharon Kedar
Investing in BioTech Maryland , Washington..., U.S.A.
Previous Investments
- • Emulate: $82000000 (Series E)
- • Hawthorne Effect: $20000000 (Series A)
- • Ultivue: $50000000 (Series D)
- • Ultivue: $22000000 (Series C)
- • Vizgen: $37000000 (Series B)
- • Vizgen: $14000000 (Series A)
- • Encodia: $75000000 (Series C)
- • Ori Biotech: $30000000 (Series A)
Sharon Kedar
Maryland - Washington, D.C., U.S.A.
Investing In
BioTech
Description
Co-Founder, Partner at Northpond Ventures
Denis Seynhaeve
Investing in Software (Web Marketplace Saas..) &b... Annapolis, Maryland, U.S.A.
Denis Seynhaeve
Annapolis, Maryland, U.S.A.
Investing In
Software (Web Marketplace Saas..) • BioTech • Businesses Solutions • FinTech (& Financials services) • IoT (& Wearables) • HealthTech (& Fitness) • Web Security (& Privacy) • Medical Devices (& Hospital Services) • Healthcare (& Wellness)
Description
Partner at Blu Venture Investors
Justin Hanes
Investing in BioTech • Pharmaceutical (& Med... Baltimore, Maryland ,..., U.S.A.
Previous Investments
- • Faze Medicines: $81000000 (Later stage VC)
Justin Hanes
Baltimore, Maryland - Boston (MA) - Waltham (MA), U.S.A.
Investing In
BioTech • Pharmaceutical (& Medicine)
Description
Venture Partner at Catalio Capital
Drew M. Pardoll
Investing in BioTech • HealthTech (& Fitness... Baltimore, Maryland, U.S.A.
Drew M. Pardoll
Baltimore, Maryland, U.S.A.
Investing In
BioTech • HealthTech (& Fitness) • Pharmaceutical (& Medicine)
Description
Venture Partner at Catalio Capital
Lindsay Redfield
Investing in Software (Web Marketplace Saas..) &b... Maryland, U.S.A.
Previous Investments
- • Endologix: $170000000 (Debt)
- • Bright Health: $160000000 (Later stage VC)
- • Fuze: $104000000 (Later stage VC)
- • Demandbase: $65000000 (Later stage VC)
- • Scopely: $60000000 (Later stage VC)
- • MapR Technologies, Inc.: $56000000 (Later stage VC)
- • Omnispace: $30000000 (Later stage VC)
- • Cologix: (Later stage VC)
Lindsay Redfield
Maryland, U.S.A.
Investing In
Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • Energy • Material Science • Medical Devices (& Hospital Services) • Investment Management
Description
Specialties: Venture Capital and Private Equity
Adair Newhall
Investing in Software (Web Marketplace Saas..) &b... Maryland, U.S.A.
Previous Investments
- • Endologix: $170000000 (Debt)
- • Bright Health: $160000000 (Later stage VC)
- • Fuze: $104000000 (Later stage VC)
- • Demandbase: $65000000 (Later stage VC)
- • Scopely: $60000000 (Later stage VC)
- • MapR Technologies, Inc.: $56000000 (Later stage VC)
- • Omnispace: $30000000 (Later stage VC)
- • Cologix: (Later stage VC)
Adair Newhall
Maryland, U.S.A.
Investing In
Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • Energy • Material Science • Medical Devices (& Hospital Services) • Investment Management
Description
As a Partner at Greenspring Associates, I lead the firm’s Healthcare and Portfolio Impact teams although I act as a generalist. The Healthcare team is focused on venture fund, direct, & secondary investments. The Portfolio Impact team helps with targeted relationships with Corporates interested in innovation, venture funds, talent acquisition, & unique IT & HC events. At Greenspring, we invest in three distinct categories: venture funds of all stages, early and growth-stage companies alongside our managers, and secondary opportunities. Each investment category informs the other, helping us capture powerful data, all while furthering our goal of building trusted relationships with venture managers and founders. Our funds incorporate one or more investment categories, each optimized for clients’ specific objectives.Founded in 2000 to focus solely on venture capital investments, Greenspring Associates believes that deep relationships built on mutual trust lead to better returns. Our mission is to serve as a value-added, lifecycle partner for fund managers and entrepreneurs on both a primary and secondary basis. With a comprehensive investment platform, data analytics capabilities, and dedicated Portfolio Impact program, we manage over $11 billion in committed capital across diversified, direct, secondary, and bespoke venture strategies for a diverse group of institutions and high net worth individuals.
Michael Miller
Investing in Software (Web Marketplace Saas..) &b... Beverly Hills Califor..., U.S.A. - U.K. - India
Michael Miller
Beverly Hills California - London - New York City (NY) - Chicago Illinois - Bethesda Maryland - Indianapolis Indiana - Annapolis Maryland - Bellevue Washington - Houston Texas - Washington D.C - Indiana - Virginia - Texas - Illinois, U.S.A. - U.K. - India
Investing In
Software (Web Marketplace Saas..) • Other • IT (& TMT) • Media • Education • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • IoT (& Wearables) • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Cannabis • Logistics (& Distribution)
Description
Perseus is a merchant bank and private equity fund management company headquartered in Washington, D.C., with an office in New York and an associated advisory firm in Munich. Perseus has invested in numerous growth equity, turnaround, and buyout transactions in the United States, Canada, and Western Europe. Perseus manages seven private equity funds and makes control equity investments in middle market companies that offer opportunities for value creation and enhancement. Since its inception in 1995, Perseus has made investments in more than 60 portfolio companies in a wide variety of industries in which Perseus and its principals have expertise, including energy, environmental, and engineering technologies; healthcare; and branded consumer products. Perseus has raised more than $1.6 billion in capital commitments. Perseus Partners VII, L.P., which was established in 2006, is a $602 million fund focused on control investments in middle market growth equity transactions principally in the energy, environmental, and engineering technology, healthcare, and branded consumer products sectors. This fund has been fully committed or reserved. Perseus also co-manages a $449 million fund that invests exclusively in life sciences companies. Growth equity and turnaround investing have been core investment focuses of Perseus since inception, supplemented by occasional opportunistic leveraged buyouts when supported by appropriate market conditions.
Tom V. Brooks
Investing in BioTech • Energy • HealthT... Baltimore, Maryland ,..., U.S.A.
Tom V. Brooks
Baltimore, Maryland - Denver (CO), U.S.A.
Investing In
BioTech • Energy • HealthTech (& Fitness) • Pharmaceutical (& Medicine)
Description
General Partner at Catalio Capital Management
Matthew Hobson
Investing in BioTech • HealthTech (& Fitness... Baltimore, Maryland, U.S.A.
Matthew Hobson
Baltimore, Maryland, U.S.A.
Investing In
BioTech • HealthTech (& Fitness) • Pharmaceutical (& Medicine)
Description
Senior Analyst at Catalio Capital Management
Lauren Maslin
Investing in BioTech Baltimore, Maryland ,..., U.S.A.
Lauren Maslin
Baltimore, Maryland - New York City, U.S.A.
Investing In
BioTech
Description
Senior Analyst at Catalio Capital Management
Jenna Glatzer
Investing in BioTech Baltimore, Maryland ,..., U.S.A.
Jenna Glatzer
Baltimore, Maryland - Rochester (NY), U.S.A.
Investing In
BioTech
Description
Analyst at Catalio Capital Management
Stephen West
Investing in Software (Web Marketplace Saas..) &b... Maryland, U.S.A.
Previous Investments
- • Endologix: $170000000 (Debt)
- • Bright Health: $160000000 (Later stage VC)
- • Fuze: $104000000 (Later stage VC)
- • Demandbase: $65000000 (Later stage VC)
- • Scopely: $60000000 (Later stage VC)
- • MapR Technologies, Inc.: $56000000 (Later stage VC)
- • Omnispace: $30000000 (Later stage VC)
- • Cologix: (Later stage VC)
Stephen West
Maryland, U.S.A.
Investing In
Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • Energy • Material Science • Medical Devices (& Hospital Services) • Investment Management
Deric Emry
Investing in Software (Web Marketplace Saas..) &b... Maryland, U.S.A.
Previous Investments
- • Endologix: $170000000 (Debt)
- • Bright Health: $160000000 (Later stage VC)
- • Fuze: $104000000 (Later stage VC)
- • Demandbase: $65000000 (Later stage VC)
- • Scopely: $60000000 (Later stage VC)
- • MapR Technologies, Inc.: $56000000 (Later stage VC)
- • Omnispace: $30000000 (Later stage VC)
- • Cologix: (Later stage VC)
Deric Emry
Maryland, U.S.A.
Investing In
Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • Energy • Material Science • Medical Devices (& Hospital Services) • Investment Management
David DiPietro
Investing in Software (Web Marketplace Saas..) &b... Maryland, U.S.A.
Previous Investments
- • Endologix: $170000000 (Debt)
- • Bright Health: $160000000 (Later stage VC)
- • Fuze: $104000000 (Later stage VC)
- • Demandbase: $65000000 (Later stage VC)
- • Scopely: $60000000 (Later stage VC)
- • MapR Technologies, Inc.: $56000000 (Later stage VC)
- • Omnispace: $30000000 (Later stage VC)
- • Cologix: (Later stage VC)
David DiPietro
Maryland, U.S.A.
Investing In
Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • Energy • Material Science • Medical Devices (& Hospital Services) • Investment Management
Anthony Giambrone
Investing in Software (Web Marketplace Saas..) &b... Maryland, U.S.A.
Previous Investments
- • Endologix: $170000000 (Debt)
- • Bright Health: $160000000 (Later stage VC)
- • Fuze: $104000000 (Later stage VC)
- • Demandbase: $65000000 (Later stage VC)
- • Scopely: $60000000 (Later stage VC)
- • MapR Technologies, Inc.: $56000000 (Later stage VC)
- • Omnispace: $30000000 (Later stage VC)
- • Cologix: (Later stage VC)
Anthony Giambrone
Maryland, U.S.A.
Investing In
Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • Energy • Material Science • Medical Devices (& Hospital Services) • Investment Management
Mary Canning
Investing in BioTech • Medical Devices (& Ho... Edinburgh , Bethesda,..., U.S.A.
Previous Investments
- • Apellis Pharmaceuticals: $47000000 (Later stage VC)
- • NodThera: $37230000 (Later stage VC)
- • Topas Therapeutics: $14000000 (Early stage VC)
- • Eternygen: $8000000 (Early stage VC)
- • Mironid: $6200000 (Early stage VC)
- • Caldan Therapeutics: $4450000 (Early stage VC)
- • Enterprise Therapeutics: $4000000 (Later stage VC)
- • Confluence Life Sciences: $2400000 (Later stage VC)
- • Slate Bio: $1750000 (Seed Round)
- • Funderbeam: $500000 (Seed Round)
Mary Canning
Edinburgh - Bethesda, Maryland, U.S.A.
Investing In
BioTech • Medical Devices (& Hospital Services) • Investment Management • Life Science
Description
Principal with Epidarex Capital; a transatlantic fund investing in early-stage, high growth life science companies in under-ventured markets within the UK and US. Epidarex funds the commercialization of ground-breaking research and new technologies to address large and unmet needs in today’s healthcare market. I have extensive experience in the commercialisation of early-stage health science technologies. As a Business Manager with Medical Research Council Technology (MRCT) I was responsible for exploitation of intellectual property arising from a number of MRC Units. I previously worked with the Scottish Enterprise Proof of Concept Programme, building and funding spin-out companies from leading Scottish academic institutions. I have a Ph.D. in molecular biology from the University of Edinburgh.Specialties: Venture capital, due diligence, IP management market research, technology transfer
Jim Lim
Investing in Software (Web Marketplace Saas..) &b... Maryland, U.S.A.
Previous Investments
- • Endologix: $170000000 (Debt)
- • Bright Health: $160000000 (Later stage VC)
- • Fuze: $104000000 (Later stage VC)
- • Demandbase: $65000000 (Later stage VC)
- • Scopely: $60000000 (Later stage VC)
- • MapR Technologies, Inc.: $56000000 (Later stage VC)
- • Omnispace: $30000000 (Later stage VC)
- • Cologix: (Later stage VC)
Jim Lim
Maryland, U.S.A.
Investing In
Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • Energy • Material Science • Medical Devices (& Hospital Services) • Investment Management
Hunter Somerville
Investing in Software (Web Marketplace Saas..) &b... Maryland, U.S.A.
Previous Investments
- • Endologix: $170000000 (Debt)
- • Bright Health: $160000000 (Later stage VC)
- • Fuze: $104000000 (Later stage VC)
- • Demandbase: $65000000 (Later stage VC)
- • Scopely: $60000000 (Later stage VC)
- • MapR Technologies, Inc.: $56000000 (Later stage VC)
- • Omnispace: $30000000 (Later stage VC)
- • Cologix: (Later stage VC)
Hunter Somerville
Maryland, U.S.A.
Investing In
Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • Energy • Material Science • Medical Devices (& Hospital Services) • Investment Management
Peter Finan
Investing in BioTech • Medical Devices (& Ho... Edinburgh , Bethesda,..., U.S.A.
Previous Investments
- • Apellis Pharmaceuticals: $47000000 (Later stage VC)
- • NodThera: $37230000 (Later stage VC)
- • Topas Therapeutics: $14000000 (Early stage VC)
- • Eternygen: $8000000 (Early stage VC)
- • Mironid: $6200000 (Early stage VC)
- • Caldan Therapeutics: $4450000 (Early stage VC)
- • Enterprise Therapeutics: $4000000 (Later stage VC)
- • Confluence Life Sciences: $2400000 (Later stage VC)
- • Slate Bio: $1750000 (Seed Round)
- • Funderbeam: $500000 (Seed Round)
Peter Finan
Edinburgh - Bethesda, Maryland, U.S.A.
Investing In
BioTech • Medical Devices (& Hospital Services) • Investment Management
